Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

TAUVID

FLORTAUCIPIR F-18

Standard Dose
30ML (8.1-51mCi/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TAUVID is listed in Drugs@FDA under application 212123 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FLORTAUCIPIR F-18 Form and strength SOLUTION;INTRAVENOUS - 30ML (8.1-51mCi/ML) Sponsor AVID RADIOPHARMS INC Submission history Latest submission status date: 2024-02-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAUVID is listed in Drugs@FDA under application 212123 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FLORTAUCIPIR F-18 Form and strength SOLUTION;INTRAVENOUS - 30ML (8.1-51mCi/ML) Sponsor AVID RADIOPHARMS INC Submission history Latest submission status date: 2024-02-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.